Diagnostic Value of Choline PET in the Preoperative Localization of Hyperfunctioning Parathyroid Gland(s): A Comprehensive Overview
Open Access
- 25 February 2021
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 9 (3) , 231
Abstract
Hyperparathyroidism is a metabolic disorder characterized by the excessive production of the parathyroid hormone. The diagnosis is based on clinical and laboratory data. In most cases the only treatment is surgery and a correct preoperatory localization of the hyperfunctioning parathyroid gland(s) is essential. Currently, ultrasonography combined with [99mTc]Tc-MIBI parathyroid scintigraphy, optionally associated with single photon emission computed tomography/computed tomography (SPECT/CT), represent the standard preoperative imaging. In recent years, a number of studies have evaluated the potential role of choline positron emission tomography (PET) in hyperparathyroidism with promising results. Most of the recent evidence underlined its higher sensitivity and diagnostic accuracy in the localization of hyperfunctioning parathyroid glands. Choline PET has a higher spatial resolution that is useful for the detection of smaller parathyroid glands and it also has shorter examination times and favorable radiation exposure. These are just a few of the aspects that support it to overcome traditional imaging. Moreover, from the preliminary data, the choline uptake mechanism seems to also have an impact on its better performance. For these reasons, if first used as second level imaging in patients with negative or inconclusive traditional imaging results, several authors have supported its use as a first line investigation. This comprehensive overview aims to provide an accurate description of the preliminary results available in the literature about the use of choline PET/CT in hyperparathyroidism and to compare these results with the performance of traditional imaging methods.Keywords
This publication has 66 references indexed in Scilit:
- Thyroid diseases cause mismatch between MIBI scan and neck ultrasound in the diagnosis of hyperfunctioning parathyroids: usefulness of FNA–PTH assayEuropean Journal of Endocrinology, 2013
- Dual-Phase PET-CT to Differentiate [18F]Fluoromethylcholine Uptake in Reactive and Malignant Lymph Nodes in Patients with Prostate CancerPLOS ONE, 2012
- Reoperations for primary hyperparathyroidism—improvement of outcome over two decadesLangenbeck's Archives of Surgery, 2012
- Risk of Malignancy in Thyroid Incidentalomas Detected by 18 F-Fluorodeoxyglucose Positron Emission Tomography: A Systematic ReviewThyroid®, 2012
- Parathyroid ScintigraphyClinical Nuclear Medicine, 2012
- Cinacalcet Reduces Serum Calcium Concentrations in Patients with Intractable Primary HyperparathyroidismThe Journal of Clinical Endocrinology & Metabolism, 2009
- Mitochondrial DNA mutations in oxyphilic and chief cell parathyroid adenomasBMC Endocrine Disorders, 2007
- Cinacalcet Hydrochloride Maintains Long-Term Normocalcemia in Patients with Primary HyperparathyroidismThe Journal of Clinical Endocrinology & Metabolism, 2005
- Parathyroid Imaging With Pertechnetate Plus Perchlorate/MIBI Subtraction ScintigraphyClinical Nuclear Medicine, 2000
- Phospholipid/Ca2+-dependent Protein Kinase Activity in Human Parathyroid Adenoma.Endocrinologia Japonica, 1987